The group's principle activity is to provide highly specialized cell culture, process development and cGMP manufacturing services for the biotechnology and biopharmaceutical industries utilizing mammalian cell culture to support pre-clinical, Phase I, II, III and commercial production. The group also provides complete package from process development through full scale manufacturing, purification and bulk packaging. The group operates from United States.
